StockCIK 1651308
BeOne Medicines Ltd. (ONC): Insider Trades and Fund Holdings
In the past 12 months, BeOne Medicines Ltd. insiders reported 0 open-market purchases worth $0 and 7 sales worth $37.1M; 6 of the sales were reported as made under a 10b5-1 trading plan.
0Insider buys, 12 months
$0Bought by insiders, 12 months
$37.1MSold by insiders, 12 months
1Tracked funds holding
Recent insider trades
Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 15, 2026.
| Filed | Insider | Type | Value |
|---|---|---|---|
| Oct 15 | Xiaodong WangDirector | ▼ SELL10b5-1 | $10.9M |
| Oct 2 | Chan Henry LeeGeneral Counsel | ▼ SELL10b5-1 | $418K |
| Sep 30 | Xiaodong WangDirector | ▼ SELL10b5-1 | $11.3M |
| Sep 10 | Xiaodong WangDirector | ▼ SELL10b5-1 | $13.4M |
| Sep 3 | Titus B. BallPrincipal Accounting Officer | ▼ SELL | $47K |
| Aug 27 | Xiaobin WuCOO | ▼ SELL10b5-1 | $106K |
| Aug 13 | Chan Henry LeeGeneral Counsel | ▼ SELL10b5-1 | $960K |
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
Insiders who traded in the past year
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Xiaodong Wang | Director | 0 | $0 | 3 | $35.6M |
| Chan Henry Lee | General Counsel | 0 | $0 | 2 | $1.38M |
| Titus B. Ball | Principal Accounting Officer | 0 | $0 | 1 | $47K |
| Xiaobin Wu | COO | 0 | $0 | 1 | $106K |
Tracked funds that report ONC
From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.
| Fund | Shares | Value | Change |
|---|---|---|---|
| Renaissance Technologies | 101,980 | $29.1M | ▲ +55.8% |
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings
Reading these numbers
Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →